MariMed Statistics
Total Valuation
MariMed has a market cap or net worth of 33.51 million. The enterprise value is 122.85 million.
| Market Cap | 33.51M |
| Enterprise Value | 122.85M |
Important Dates
The last earnings date was Wednesday, May 13, 2026.
| Earnings Date | May 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
MariMed has 398.95 million shares outstanding. The number of shares has increased by 3.38% in one year.
| Current Share Class | 398.95M |
| Shares Outstanding | 398.95M |
| Shares Change (YoY) | +3.38% |
| Shares Change (QoQ) | +0.54% |
| Owned by Insiders (%) | 10.68% |
| Owned by Institutions (%) | 2.26% |
| Float | 332.71M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.21 |
| PB Ratio | 0.63 |
| P/TBV Ratio | 4.19 |
| P/FCF Ratio | 5.51 |
| P/OCF Ratio | 4.56 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 10.86, with an EV/FCF ratio of 20.22.
| EV / Earnings | -9.63 |
| EV / Sales | 0.77 |
| EV / EBITDA | 10.86 |
| EV / EBIT | n/a |
| EV / FCF | 20.22 |
Financial Position
The company has a current ratio of 0.95, with a Debt / Equity ratio of 1.71.
| Current Ratio | 0.95 |
| Quick Ratio | 0.27 |
| Debt / Equity | 1.71 |
| Debt / EBITDA | 8.76 |
| Debt / FCF | 15.01 |
| Interest Coverage | -0.17 |
Financial Efficiency
Return on equity (ROE) is -20.01% and return on invested capital (ROIC) is -0.94%.
| Return on Equity (ROE) | -20.01% |
| Return on Assets (ROA) | -0.40% |
| Return on Invested Capital (ROIC) | -0.94% |
| Return on Capital Employed (ROCE) | -0.95% |
| Weighted Average Cost of Capital (WACC) | 8.01% |
| Revenue Per Employee | 186,375 |
| Profits Per Employee | -14,732 |
| Employee Count | 923 |
| Asset Turnover | 0.79 |
| Inventory Turnover | 2.69 |
Taxes
In the past 12 months, MariMed has paid 3.41 million in taxes.
| Income Tax | 3.41M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -1.18% in the last 52 weeks. The beta is 1.34, so MariMed's price volatility has been higher than the market average.
| Beta (5Y) | 1.34 |
| 52-Week Price Change | -1.18% |
| 50-Day Moving Average | 0.08 |
| 200-Day Moving Average | 0.10 |
| Relative Strength Index (RSI) | 52.82 |
| Average Volume (20 Days) | 973,375 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, MariMed had revenue of 161.40 million and -12.76 million in losses. Loss per share was -0.04.
| Revenue | 161.40M |
| Gross Profit | 58.07M |
| Operating Income | -1.30M |
| Pretax Income | -9.33M |
| Net Income | -12.76M |
| EBITDA | 10.42M |
| EBIT | -1.30M |
| Loss Per Share | -0.04 |
Balance Sheet
The company has 7.94 million in cash and 91.21 million in debt, with a net cash position of -83.27 million or -0.21 per share.
| Cash & Cash Equivalents | 7.94M |
| Total Debt | 91.21M |
| Net Cash | -83.27M |
| Net Cash Per Share | -0.21 |
| Equity (Book Value) | 53.45M |
| Book Value Per Share | 0.12 |
| Working Capital | -2.97M |
Cash Flow
In the last 12 months, operating cash flow was 7.35 million and capital expenditures -1.27 million, giving a free cash flow of 6.08 million.
| Operating Cash Flow | 7.35M |
| Capital Expenditures | -1.27M |
| Depreciation & Amortization | 11.72M |
| Net Borrowing | -4.46M |
| Free Cash Flow | 6.08M |
| FCF Per Share | 0.02 |
Margins
Gross margin is 35.98%, with operating and profit margins of -0.80% and -7.90%.
| Gross Margin | 35.98% |
| Operating Margin | -0.80% |
| Pretax Margin | -5.78% |
| Profit Margin | -7.90% |
| EBITDA Margin | 6.45% |
| EBIT Margin | -0.80% |
| FCF Margin | 3.77% |
Dividends & Yields
MariMed does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -3.38% |
| Shareholder Yield | -3.38% |
| Earnings Yield | -38.07% |
| FCF Yield | 18.13% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |